Skip to main content

Advertisement

Table 1 Clinical characteristics of the patients at baseline

From: Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Baseline clinical characteristic Patient nr. 150
Age (years)—mean ± SD 64.3 ± 10.4
Sex (male)—no. (%) 108 (72.0)
Race (Caucasian)—no. (%) 140 (93.3)
Body-mass index (kg/m2)—mean ± SD; no. 29.5 ± 5.1; 148a
Risk factors—no. (%)
 Diabetes mellitus type 1 10 (6.7)
 Diabetes mellitus type 2 140 (93.3)
 Insulin-dependent diabetes mellitus 47 (31.3)
 Diabetes mellitus treated with oral antidiabetic 117 (78.0)
 HbA1c (mmol/mol)—mean ± SD; no. 55.5 ± 11.5; 42a
 Arterial hypertension 104 (69.3)
 Hypercholesterolemia 100 (66.7)
 Family history of cardiovascular disease 59 (39.3)
 Current smoker 35 (23.3)
Medical history—no. (%)
 Previous ACS 41 (27.3)
 Previous PCI 37 (24.7)
 Previous CABG 8 (5.3)
 Previous CVA or TIA 10 (8.7)
 Severe chronic renal failureb 4 (2.7)
 Chronic pulmonary obstructive diseasec 11 (7.3)
Clinical presentation—no. (%)
 Acute coronary syndrome 73 (48.7)
  ST-segment elevation myocardial infarction 18 (12.0)
  Non-ST-segment elevation myocardial infarction 29 (19.3)
  Unstable angina pectoris 26 (17.3)
 Non-acute coronary syndrome 77 (51.3)
  Stable angina pectoris 59 (39.3)
  Silent ischemia 8 (5.3)
  Other 10 (6.7)
  1. Plus–minus values are means ± standard and the curved numbers a represent the known total of which the variable was calculated. b Renal insufficiency was defined as estimated glomerular filtration rate of less than 30 ml per minute per 1.73 m2 of body surface area (GFR < 30 ml/min/1.73 m2). c Chronic pulmonary obstructive disease was defined as ≥ Gold class II
  2. ACS acute coronary syndrome, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, CVA cerebrovascular accident, TIA transient ischemic attack